Learn About Ibogaine

Research-backed articles on ibogaine treatment, safety, legality, and the science behind this powerful psychedelic medicine.

Legality & Access05-01-2026

Ibogaine Legal Status in the UK

Ibogaine is a Class A controlled substance in the UK. Learn about current laws, enforcement, treatment access, and recent legal developments. Last verified May 2026.

5 min read
Addiction Treatment05-01-2026

Ibogaine for Heroin Addiction | Research & Evidence

Explore clinical research on ibogaine for heroin addiction. Evidence from observational studies, safety considerations, and how it compares to methadone and buprenorphine.

6 min read
How It Works05-01-2026

Ibogaine Pharmacokinetics: How It Moves Through the Body

Learn how ibogaine is absorbed, distributed, metabolized, and eliminated — and why its unique pharmacokinetics matter for safety and treatment duration.

7 min read
Research & News05-01-2026

US Congress & Ibogaine: The Push to Reschedule

Explore the congressional bills, veteran advocacy, and clinical trials driving the push to reschedule ibogaine from Schedule I in the United States.

7 min read
What Is Ibogaine04-30-2026

Howard Lotsof & Ibogaine's Addiction Discovery

How Howard Lotsof accidentally discovered ibogaine's addiction-interrupting properties in 1962 and spent decades fighting to bring it to clinical research.

7 min read
How It Works04-30-2026

Ibogaine & NMDA Receptors: Interrupting Addiction Memory

Learn how ibogaine acts on NMDA receptors to disrupt addiction memory, reduce cravings, and why researchers think this mechanism matters for opioid treatment.

7 min read
Research & News04-29-2026

ATAI Life Sciences & Tabernanthaiboga

ATAI Life Sciences is developing tabernanthaiboga (TBG), a non-hallucinogenic ibogaine analog. Learn what the research shows, trial status, and what it means for treatment.

7 min read
How It Works04-29-2026

Ibogaine & the Default Mode Network

Explore what neuroscience research reveals about how ibogaine affects the default mode network, brain connectivity, and addiction-related neural patterns.

7 min read
Research & News04-28-2026

Ibogaine Breakthrough Therapy Designation Explained

The FDA granted ibogaine Breakthrough Therapy Designation for opioid use disorder. Learn what this means for research, access, and future approval timelines.

6 min read
How It Works04-28-2026

Ibogaine & Kappa Opioid Receptors Explained

Learn how ibogaine acts as a kappa opioid receptor agonist (KOR/KRA), what that means biologically, and why it matters for addiction and depression research.

7 min read
Research & News04-27-2026

Weekly Ibogaine Digest — Week of 2026-04-27

Trump Signs Psychedelics Executive Order, FDA Clears First U.S. Ibogaine-Derivative Trial

4 min read
How It Works04-27-2026

Ibogaine and Sigma Receptors: What the Science Says

Explore the science behind ibogaine's interaction with sigma receptors, what researchers have found, and why this mechanism matters for addiction and depression research.

7 min read
Research & News04-23-2026

Weekly Ibogaine Digest — Week of 2026-04-20

Trump Signs Executive Order Naming Ibogaine, Directing FDA and DEA to Open Research Pathways

4 min read
What Is Ibogaine04-22-2026

Ibogamine: Alkaloid Profile & Research

Ibogamine: chemical profile, mechanism of action, medical research, safety data, legal status, and FAQs. Evidence-based reference with peer-reviewed citations.

8 min read
Comparisons04-22-2026

Ibogaine vs Ketamine Therapy Compared

Ibogaine vs ketamine therapy: unbiased comparison of mechanisms, evidence, safety, cost, and access to help you make an informed decision.

5 min read
Safety & Screening04-22-2026

Ibogaine Cardiac Risks & QTc Prolongation

Ibogaine carries serious cardiac risks including fatal QTc prolongation. Learn the specific contraindications, screening protocols, and monitoring requirements.

5 min read
Comparisons04-22-2026

Ibogaine vs Psilocybin for Depression

Objective comparison of ibogaine and psilocybin for depression. Explore mechanisms, clinical evidence, safety profiles, cost, access, and who each treatment may suit.

5 min read
Comparisons04-22-2026

Ibogaine vs MDMA-Assisted Therapy

Objective comparison of ibogaine and MDMA-assisted therapy: mechanisms, evidence, safety, cost, and who each treatment may be best suited for.

5 min read
Comparisons04-22-2026

Ibogaine vs Ayahuasca: Key Differences

Objective comparison of ibogaine vs ayahuasca: mechanisms, evidence, safety, cost, and access. Research-based findings to help you understand both treatments.

5 min read
Comparisons04-22-2026

Ibogaine vs Naltrexone for Opioid Addiction

Ibogaine vs naltrexone for opioid addiction: compare mechanisms, evidence, safety, cost, and access to make a more informed treatment decision.

5 min read
Comparisons04-22-2026

Ibogaine vs LSD for Addiction Treatment

Objective comparison of ibogaine vs LSD for addiction treatment. Review mechanisms, evidence, safety, cost, and access to make an informed decision.

5 min read
Comparisons04-22-2026

Ibogaine vs Traditional Rehab Compared

Ibogaine vs traditional rehab: compare mechanisms, evidence, safety, cost, and access side by side to understand how these approaches differ for addiction treatment.

5 min read
Comparisons04-22-2026

Ibogaine vs Rapid Detox for Opioid Withdrawal

Ibogaine vs rapid detox for opioid withdrawal: compare mechanisms, evidence, safety risks, costs, and who each approach may suit best.

5 min read
Comparisons04-22-2026

Ibogaine vs Buprenorphine: Long-Term Outcomes

Objective comparison of ibogaine vs buprenorphine for opioid use disorder. Mechanisms, long-term outcomes, safety profiles, costs, and access explained.

5 min read
Comparisons04-22-2026

Ibogaine vs Psilocybin for PTSD

Ibogaine vs psilocybin for PTSD: compare mechanisms, clinical evidence, safety profiles, cost, access, and who each treatment may suit best.

5 min read
Comparisons04-22-2026

Ibogaine vs SSRIs for Depression

Objective comparison of ibogaine and SSRIs for depression. Explore mechanisms, evidence, safety, cost, and access to make an informed decision.

5 min read
Comparisons04-22-2026

Ibogaine vs Kratom for Opioid Withdrawal

Objective comparison of ibogaine vs kratom for opioid withdrawal. Mechanism, evidence, safety, cost, and access—research findings without bias.

5 min read
Comparisons04-22-2026

Ibogaine vs 5-MeO-DMT: Effects & Use Compared

Ibogaine vs 5-MeO-DMT: compare mechanisms, evidence, safety, cost, and who each psychedelic treatment may suit. Objective research-based breakdown.

5 min read
Comparisons04-22-2026

Ibogaine vs Iboga Root Bark: Key Differences

Ibogaine vs iboga root bark compared across mechanism, potency, safety, cost, and access. Objective research-based breakdown to help you understand both forms.

5 min read
Safety & Screening04-22-2026

Ibogaine Drug Interactions & Contraindications

Critical drug interactions and contraindications for ibogaine treatment. Learn which medications, substances, and conditions make ibogaine life-threatening.

5 min read
Protocols & Preparation04-22-2026

How to Prepare for Ibogaine Treatment

Essential ibogaine preparation steps: medical screening, drug tapers, diet, and what to expect. Evidence-based safety guidance before your treatment.

5 min read
Safety & Screening04-22-2026

Cardiac Screening Before Ibogaine Treatment | Safety Guide

Complete guide to required cardiac screening before ibogaine treatment. Learn ECG requirements, contraindications, and why skipping screening can be fatal.

5 min read
Safety & Screening04-22-2026

Ibogaine Contraindications: Who Should Not Take It

Detailed guide to absolute and relative contraindications for ibogaine treatment, including heart conditions, drug interactions, and documented risk factors.

5 min read
Safety & Screening04-22-2026

Ibogaine Deaths: Causes, Statistics & Prevention

Ibogaine-related deaths: documented causes, mortality statistics, cardiac risks, and how accredited clinics prevent fatalities. Evidence-based safety guidance.

5 min read
Safety & Screening04-22-2026

Post-Ibogaine Integration: 90-Day Safety Guide

A practical, clinically informed 90-day integration guide after ibogaine treatment — covering cardiac risks, relapse prevention, mental health, and recovery milestones.

5 min read
Safety & Screening04-22-2026

Ibogaine Dosing Protocols: Safety Guide

Flood dose, booster, and microdose ibogaine protocols explained with safety thresholds, contraindications, and clinical guidance. Essential reading before treatment.

5 min read
Safety & Screening04-22-2026

Medications to Stop Before Ibogaine Treatment

Critical medication washout guide before ibogaine treatment. Learn which drugs must be stopped, for how long, and why — with named contraindications and risks.

5 min read
Safety & Screening04-22-2026

QTc Prolongation & Ibogaine Safety

Ibogaine prolongs the QTc interval and can cause fatal arrhythmias. Learn which patients are at risk, required cardiac screening, and safer protocols.

5 min read
Safety & Screening04-22-2026

Psychological Screening for Ibogaine | Safety Guide

Learn which psychological conditions require screening before ibogaine treatment, why screening matters, and what qualified clinics assess. Evidence-based safety guide.

5 min read
What Is Ibogaine04-22-2026

The Bwiti Tradition: Iboga in African Spiritual Practice

Explore how the Bwiti tradition of Central Africa uses iboga root bark in initiation and healing ceremonies, and why cultural context matters for modern research.

7 min read
Research & News04-22-2026

DemeRx & the Race to FDA-Approve Ibogaine

DemeRx led early clinical efforts to bring ibogaine through FDA approval for opioid addiction. Learn what the trials found, why progress stalled, and what comes next.

7 min read
Addiction Treatment04-22-2026

Does Ibogaine Work for Alcohol Addiction?

Explore the science, clinical trials, and real-world evidence on ibogaine for alcohol use disorder. Learn what research says about outcomes, risks, and access.

7 min read
Clinical Trials04-22-2026

FDA & Ibogaine: Where Does Approval Stand in 2026

Ibogaine remains Schedule I in the US, but FDA has granted Breakthrough Therapy status to at least one sponsor. Here's where regulatory approval stands in 2026.

7 min read
Legality & Access04-22-2026

Global Ibogaine Therapy Alliance: Standards & Advocacy

Learn how the Global Ibogaine Therapy Alliance shapes safety standards, provider training, and policy advocacy for ibogaine treatment worldwide.

7 min read
Addiction Treatment04-22-2026

How Ibogaine Resets Opioid Addiction

Explore how ibogaine interrupts opioid dependence, reduces withdrawal, and may reset brain receptors. Science, risks, legal status, and research explained.

7 min read
How It Works04-22-2026

How Ibogaine Works on the Brain

Explore the neurochemistry of ibogaine: how it interacts with opioid, serotonin, and dopamine systems to produce its effects and potential therapeutic benefits.

7 min read
What Is Ibogaine04-22-2026

How Long Does Ibogaine Last: Timeline of Effects

Ibogaine effects can last 24–36 hours or more. Learn the full timeline—acute, plateau, and afterglow phases—backed by clinical research and named trials.

7 min read
Treatment Centers04-22-2026

How Much Does Ibogaine Treatment Cost?

Ibogaine treatment typically costs $5,000–$15,000+ at licensed clinics abroad. Learn what's included, why prices vary, and how to evaluate your options.

7 min read
Treatment Centers04-22-2026

How to Choose an Ibogaine Clinic

Learn what to look for when choosing an ibogaine clinic — medical screening, staff credentials, protocols, and red flags to avoid. Research guide for 2026.

7 min read
Treatment Centers04-22-2026

Find a Reputable Ibogaine Provider: Safety Checklist

Learn what separates safe ibogaine providers from dangerous ones. Use our research-backed checklist covering screening, medical oversight, and red flags.

7 min read
What Is Ibogaine04-22-2026

The Iboga Plant: Origins, History & Culture

Explore the iboga plant's Central African roots, its sacred role in Bwiti tradition, and how it became the source of ibogaine research worldwide.

7 min read
Protocols & Preparation04-22-2026

Ibogaine Afterglow Period Explained

Learn what the ibogaine afterglow period is, how long it lasts, what the science says, and why integration during this window matters for lasting outcomes.

7 min read
Mental Health04-22-2026

Ibogaine and Trauma: The Connection to PTSD

Explore how ibogaine may address PTSD and trauma at a neurological level, what research shows, and what patients should know before considering treatment.

7 min read
How It Works04-22-2026

Ibogaine and BDNF: How It Promotes Neuronal Growth

Explore how ibogaine increases BDNF levels, promotes neuroplasticity, and may support neuronal growth in addiction and depression research.

7 min read
Clinical Trials04-22-2026

Ibogaine Clinical Trials: What the Research Shows

Explore current ibogaine clinical trials, key findings on addiction and PTSD, safety data, and what the science says about this emerging treatment.

7 min read
Treatment Centers04-22-2026

Ibogaine Clinics in Mexico: What to Know

Planning ibogaine treatment in Mexico? Learn about clinic standards, safety protocols, costs, legal status, and what questions to ask before you go.

7 min read
What Is Ibogaine04-22-2026

Ibogaine Drug Test: Detection Windows & Methods

How long does ibogaine show up on a drug test? Learn detection windows, testing methods, and what labs actually screen for in urine, blood, and hair.

7 min read
Protocols & Preparation04-22-2026

The Ibogaine Experience: A Week-by-Week Guide

What happens before, during, and after ibogaine treatment? A week-by-week breakdown of the experience, from screening to long-term integration.

8 min read
Addiction Treatment04-22-2026

Ibogaine for First Responders: Addiction & Trauma

Learn how ibogaine is being studied for first responder PTSD, addiction, and trauma. Research, risks, legal status, and clinical trial updates explained.

7 min read
Addiction Treatment04-22-2026

Ibogaine for Veterans: Why They Seek Treatment Abroad

Veterans are traveling to Mexico, Canada, and beyond for ibogaine therapy. Learn what the research shows, the risks involved, and the legal landscape.

7 min read
How It Works04-22-2026

Ibogaine and GDNF: The Neuroprotective Connection

Explore how ibogaine elevates GDNF levels in the brain, what this means for addiction and neurodegeneration research, and what the science currently shows.

7 min read
Safety & Screening04-22-2026

Ibogaine Harm Reduction Outside Clinical Settings

Ibogaine carries serious cardiac and safety risks. Learn evidence-based harm reduction information for those researching use outside formal clinical environments.

7 min read
Treatment Centers04-22-2026

Ibogaine Insurance Coverage: Can You Get Reimbursed?

Ibogaine is Schedule I in the US, making insurance reimbursement nearly impossible domestically. Learn what options exist for treatment abroad and what to expect.

7 min read
Protocols & Preparation04-22-2026

Ibogaine Integration: Making the Most of Your Experience

Learn evidence-informed strategies for ibogaine integration, including journaling, therapy, lifestyle changes, and community support to sustain healing.

7 min read
Research & News04-22-2026

Ibogaine & Neuroplasticity: Brain Repair Research

Explore emerging research on ibogaine and neuroplasticity, including GDNF, BDNF signaling, synaptic repair, and what clinical trials are revealing about brain recovery.

7 min read
How It Works04-22-2026

Ibogaine & the Opioid Receptor System

How ibogaine interacts with mu, kappa, and delta opioid receptors — and what the science says about its anti-addictive and withdrawal-interrupting effects.

7 min read
Research & News04-22-2026

Ibogaine Phase 2 Clinical Trials: 2025 Update

A detailed look at ibogaine Phase 2 clinical trials currently underway, what the research shows, and what it means for future treatment access.

7 min read
Protocols & Preparation04-22-2026

Ibogaine Preparation: Diet & Lifestyle Guide

Learn the essential diet and lifestyle steps before ibogaine treatment, including fasting protocols, medication tapering, and cardiac screening requirements.

7 min read
Treatment Centers04-22-2026

Ibogaine Retreat vs Clinic: Which Is Right for You?

Comparing ibogaine retreats and clinics: medical oversight, cost, setting, safety protocols, and how to choose the right option for your needs.

7 min read
Legality & Access04-22-2026

Ibogaine Schedule I Status: Why Is It Illegal in the US

Ibogaine is Schedule I in the US — but why? Explore the DEA classification, the science behind it, and what researchers and lawmakers are doing to change it.

7 min read
How It Works04-22-2026

Ibogaine & Serotonin: Antidepressant Mechanism

How does ibogaine affect serotonin and produce antidepressant effects? Explore the neuroscience, receptor targets, GDNF signaling, and current research.

7 min read
Safety & Screening04-22-2026

Ibogaine Side Effects: What to Expect

Learn about ibogaine's short- and long-term side effects, cardiac risks, neurological effects, and what medical screening can reduce your risk.

7 min read
Safety & Screening04-22-2026

Ibogaine and SSRI Interactions: What You Must Know

Ibogaine and SSRIs can interact dangerously. Learn about serotonin syndrome risk, washout periods, and why this combination requires expert medical oversight.

7 min read
Legality & Access04-22-2026

Ibogaine State Legislation: Which States Are Moving Forward

Track which US states are advancing ibogaine legislation in 2026, from decriminalization bills to regulated clinical trial frameworks. Updated state-by-state breakdown.

7 min read
Clinical Trials04-22-2026

Ibogaine Success Rates: What Research Reports

Explore what peer-reviewed studies and treatment clinics report about ibogaine success rates for addiction, PTSD, and depression. Evidence reviewed.

7 min read
Treatment Centers04-22-2026

Ibogaine Treatment Costs: Mexico vs Other Countries

Compare ibogaine treatment costs in Mexico, Canada, Portugal, and beyond. Learn what's included, why prices vary, and how to evaluate quality vs. cost.

7 min read
Safety & Screening04-22-2026

Ibogaine Underground: Risks of Unregulated Use

Unregulated ibogaine use carries serious cardiac, psychological, and legal risks. Learn what the research says and why medical screening matters.

7 min read
Clinical Trials04-22-2026

Ibogaine & the US Military: The VETS Study

Explore the VETS study on ibogaine for US veterans with PTSD and TBI. Learn about findings, safety protocols, legal status, and what comes next.

7 min read
What Is Ibogaine04-22-2026

Ibogaine Visions: What Patients See & Why It Matters

Explore what patients experience during ibogaine visions, the neuroscience behind them, and why researchers believe these visionary states may drive therapeutic outcomes.

7 min read
Legality & Access04-22-2026

Is Ibogaine Legal in the US in 2026?

Ibogaine is Schedule I in the US, but state laws, federal research exemptions, and veteran-access bills are shifting the landscape in 2026. Learn what's changing.

7 min read
Research & News04-22-2026

MAPS and Ibogaine: FDA Breakthrough Designation Push

Explore how MAPS and allied researchers are pursuing FDA Breakthrough Therapy designation for ibogaine, what the evidence shows, and what it means for patients.

7 min read
Research & News04-22-2026

Microdosing Ibogaine: What the Research Says

Explore what current research says about microdosing ibogaine, including proposed mechanisms, early clinical findings, safety considerations, and legal status.

7 min read
Research & News04-22-2026

New Zealand Ibogaine Reclassification: A Reform Model

New Zealand reclassified ibogaine from Class A to Class C, opening supervised clinical access. Learn what this reform means for patients and global policy.

7 min read
How It Works04-22-2026

Noribogaine & Ibogaine's Long-Term Effects

Explore how noribogaine, ibogaine's primary metabolite, drives lasting antidepressant and anti-addiction effects. Research, mechanisms, and what science shows.

7 min read
How It Works04-22-2026

Noribogaine: The Metabolite Behind Long-Term Effects

Noribogaine, ibogaine's primary metabolite, may explain lasting addiction relief and mood changes. Learn what the science says about how it works.

7 min read
Research & News04-22-2026

Ibogaine & Opioid Relapse Prevention: New Data

New clinical data on ibogaine for opioid use disorder and relapse prevention. Learn what trials show, how it works, safety risks, and legal status in 2026.

7 min read
Research & News04-22-2026

Stanford MIMS Trial: Ibogaine for Veterans

Explore the Stanford MIMS trial studying ibogaine for veterans with PTSD and TBI. Learn what the research found, how the study worked, and what comes next.

7 min read
Research & News04-22-2026

Tabernanthe Iboga & Cardiac Risk: What Research Shows

Exploring whether Tabernanthe iboga or its alkaloids can deliver ibogaine's therapeutic effects with a safer cardiac profile. Current science explained.

7 min read
What Is Ibogaine04-22-2026

What Is Ibogaine and How Does It Work

Learn what ibogaine is, how it works in the brain, its origins, legal status, and what research says about its potential therapeutic uses. Science-based overview.

7 min read
Protocols & Preparation04-22-2026

What to Expect During Ibogaine Treatment

Learn what happens before, during, and after ibogaine treatment — from medical screening to the acute experience and recovery. Research-backed, safety-focused.

7 min read
Safety & Screening04-22-2026

Who Is a Good Candidate for Ibogaine Treatment?

Learn who may benefit from ibogaine treatment, what medical screening involves, and which conditions make someone a poor candidate. Evidence-based overview.

7 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Panama

Panama has no federal scheduling of ibogaine, making it one of Latin America's most accessible destinations for legal ibogaine treatment. Last verified April 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Belize

Ibogaine is unscheduled in Belize, creating a legal grey area. Learn about clinic access, recent developments, and risks. Last verified April 22, 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Peru

Ibogaine is unscheduled in Peru, existing in a legal gray area. Learn about treatment access, clinics, recent developments, and risks. Last verified April 22, 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in DR Congo

Is ibogaine legal in the Democratic Republic of Congo? Current scheduling status, treatment centers, access methods, and legal developments. Last verified April 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Cameroon

Ibogaine is unscheduled in Cameroon, where iboga holds deep traditional roots. Learn about legal status, treatment access, and recent developments. Last verified April 22, 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Senegal

Ibogaine is unscheduled in Senegal, where iboga holds deep cultural and religious roots. Last verified April 22, 2026. Learn about access, clinics, and risks.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Czech Republic

Ibogaine is unscheduled in the Czech Republic. Learn about current laws, treatment access, clinics, and recent legal developments. Last verified April 22, 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Uruguay

Ibogaine is unscheduled in Uruguay, meaning it is not explicitly controlled. Learn about clinic access, legal context, and recent developments. Last verified April 22, 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Ireland

Ibogaine is a controlled substance in Ireland under the Misuse of Drugs Act. Learn about scheduling, clinics, access, and recent legal developments.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Italy

Ibogaine is a controlled substance in Italy. Learn about current laws, treatment access, recent developments, and risks. Last verified April 22, 2026.

5 min read
Legality & Access04-22-2026

Ibogaine Legal Status in Argentina

Argentina does not schedule ibogaine federally. Learn about clinics, access methods, recent developments, and risks. Last verified April 22, 2026.

5 min read
What Is Ibogaine04-21-2026

Noribogaine: Mechanism, Research & Safety

Comprehensive reference on noribogaine: how it works, clinical research, cardiac safety, drug interactions, legal status, and FAQs. Cited peer-reviewed sources.

8 min read
Addiction Treatment04-20-2026

Ibogaine for Opioid Addiction

Explore the clinical evidence, safety profile, and research on ibogaine as a treatment for opioid addiction. Learn what studies show and what remains unknown.

6 min read
Mental Health04-20-2026

Ibogaine for Depression | Research & Evidence

Explore what research shows about ibogaine for depression. Evidence, mechanisms, limitations, and safety considerations explained clearly.

6 min read
Mental Health04-20-2026

Ibogaine for PTSD | Evidence & Research

Explore ibogaine research for PTSD, including the Stanford veterans study. Learn what the evidence shows, risks, and how it compares to current treatments.

6 min read
Mental Health04-20-2026

Ibogaine for Parkinson's Disease

Explore early research on ibogaine for Parkinson's disease, including GDNF pathways, dopaminergic neuroprotection, safety considerations, and current evidence gaps.

6 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Jamaica

Ibogaine is unscheduled in Jamaica, making it one of the few countries where legal ibogaine treatment centers openly operate. Last verified January 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Mexico

Ibogaine is unscheduled under Mexico's Ley General de Salud. Clinics operate legally in Baja California. Learn about access, risks, and recent developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Portugal 2026

Portugal's ibogaine legal status is a genuine gray area. Personal use is decriminalized, but scheduling under Decree-Law 15/93 remains disputed. Last verified April 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in the Netherlands

Ibogaine is not scheduled under the Dutch Opium Act, making it legally unscheduled in the Netherlands. Learn about clinics, access, and recent regulatory discussions.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Costa Rica

Ibogaine is unscheduled under Costa Rican law, making the country a leading destination for ibogaine treatment tourism. Last verified: April 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in the United States

Ibogaine is a federal Schedule I controlled substance in the US. Learn about state-level research exceptions, treatment access, and recent legislative developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Canada

Ibogaine is Schedule III under Canada's CDSA. Learn about Section 56 exemptions, clinical trials, treatment access, and recent legal developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in New Zealand

Ibogaine is a Class C controlled substance in New Zealand under the Misuse of Drugs Act 1975. Learn about penalties, access, and recent developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in South Africa

Ibogaine appears unscheduled under SAHPRA in South Africa, enabling active treatment clinics. Understand the legal landscape, risks, and how access works.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Brazil

Ibogaine is controlled and prohibited in Brazil under ANVISA's scheduling framework. Learn about legal status, treatment access, and recent developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Australia

Ibogaine is a Schedule 9 Prohibited Substance in Australia. Learn about the current law, SAS pathways, treatment access, and recent developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Germany 2026

Ibogaine is listed in Anlage II of Germany's BtMG. Unlicensed possession and supply carry criminal penalties. Last verified: April 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in France

Ibogaine is classified as a stupéfiant (narcotic) under French national law. Learn about France's domestic scheduling, enforcement, and treatment access. Last verified: April 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Switzerland

Switzerland's ibogaine legal status explained: scheduling under BetmKV, medical access pathways, treatment centers, and recent developments. Last verified April 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Gabon

Iboga is a protected national heritage plant in Gabon. Learn about legal status, treatment access, export restrictions, and the Bwiti tradition. Last verified April 2026.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Colombia

Ibogaine is unscheduled under Colombian law and not listed on MINJUSTICIA controlled substance schedules. Learn about treatment centers and legal context.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Israel

Ibogaine is a controlled substance in Israel under the Dangerous Drugs Ordinance, yet Israel hosts landmark clinical research including a completed Nature Medicine trial.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Spain

Ibogaine exists in a legal gray area in Spain — not explicitly scheduled, yet not approved. Learn about clinics, access, and recent developments.

5 min read
Legality & Access04-20-2026

Ibogaine Legal Status in Thailand

Ibogaine is understood to be a Category 1 narcotic in Thailand under strict drug laws. Learn what this means for treatment access. Last verified: April 2026.

5 min read
Mental Health04-20-2026

Ibogaine for Eating Disorders

Explore what early research and case reports say about ibogaine for eating disorders like anorexia and bulimia. Evidence, risks, and current landscape.

6 min read
Addiction Treatment04-20-2026

Ibogaine for Alcohol Use Disorder

Explore the evidence on ibogaine for alcohol use disorder — clinical research, safety considerations, and how it compares to existing treatments.

6 min read
Mental Health04-20-2026

Ibogaine for Anxiety Disorders

Explore what the research says about ibogaine for anxiety disorders — evidence, limitations, safety risks, and how it compares to current treatments.

6 min read
Addiction Treatment04-20-2026

Ibogaine for Methamphetamine Addiction

Explore the early-stage research on ibogaine for methamphetamine use disorder, what the evidence shows, key limitations, and safety considerations.

6 min read
Addiction Treatment04-20-2026

Ibogaine for Cocaine Addiction

Explore what the research shows about ibogaine for cocaine use disorder, including trial data, mechanisms, safety risks, and how it compares to current treatments.

6 min read
Mental Health04-20-2026

Ibogaine for Treatment-Resistant Depression

Explore the emerging research on ibogaine for treatment-resistant depression — what clinical evidence exists, how it may work, and key safety considerations.

6 min read
Addiction Treatment04-20-2026

Ibogaine for Nicotine & Tobacco Addiction

Explore the early-stage evidence on ibogaine for nicotine and tobacco addiction, including preclinical findings, case reports, mechanisms, and key safety considerations.

6 min read
Mental Health04-20-2026

Ibogaine for Traumatic Brain Injury

Explore emerging research on ibogaine for traumatic brain injury, including the 2024 Stanford/VETS veterans study and key safety considerations.

6 min read
Mental Health04-20-2026

Ibogaine for OCD: Research & Evidence

Explore what the research shows about ibogaine for OCD, including clinical trial results, mechanisms, safety considerations, and how it compares to existing treatments.

6 min read
Mental Health04-20-2026

Ibogaine for Chronic Pain | Research & Evidence

Explore what research shows about ibogaine for chronic pain — mechanisms, preclinical evidence, safety risks, and how it compares to current treatments.

6 min read
Addiction Treatment04-20-2026

Ibogaine for Benzodiazepine Addiction

Explore what the research says about ibogaine for benzodiazepine addiction — evidence, safety risks, limitations, and how it compares to current treatments.

6 min read
Addiction Treatment04-20-2026

Ibogaine for Polydrug Addiction

Explore the evidence on ibogaine for polydrug addiction. Review clinical data, mechanisms, safety risks, and how it compares to existing treatments.

6 min read
What Is Ibogaine04-19-2026

Ibogaine: Mechanism, Research & Safety | Drug Reference

Comprehensive reference on ibogaine: how it works, clinical research, cardiac safety risks, drug interactions, legal status worldwide, and frequently asked questions.

8 min read
Comparisons04-19-2026

Ibogaine vs Methadone for Opioid Addiction | Comparison

Ibogaine vs methadone for opioid addiction: compare mechanisms, evidence, safety, cost, and access to make an informed decision. Research-based, unbiased.

5 min read
Comparisons04-19-2026

Ibogaine vs Suboxone: How They Compare

Objective comparison of ibogaine and Suboxone for opioid use disorder. Explore mechanism, evidence, safety, cost, access, and who each treatment suits best.

5 min read